AGA Clinical Practice Guideline on the Management of Pouchitis and Inflammatory Pouch Disorders

Keyphrases

• Clinical Practice Guidelines 100%
• Pouch 100%
• Pouchitis 100%
• American Gastroenterological Association 100%
• Antibiotics 53%
• Ulcerative Colitis 23%
• Crohn's Disease 23%
• Immunosuppressive Therapy 23%
• Corticosteroids 15%
• Ileal Pouch-anal Anastomosis 15%
• Cuffitis 15%
• Inflammatory Bowel Disease 7%
• Lack of Response 7%
• Assessment Development 7%
• Evaluation Assessment 7%
• Patient-centered Outcomes 7%
• Evaluation Framework 7%
• Mesalamine 7%
• Patient Management 7%
• Knowledge Gaps 7%
• Antibiotic Therapy 7%
• Assessment Framework 7%
• Restorative Proctocolectomy 7%
• Optimal Management 7%
• Development Framework 7%
• Common Complications 7%
• Knowledge Areas 7%
• Inflammatory Conditions 7%
• Recurrent Episodes 7%
• Topical Corticosteroids 7%
• Grading of Recommendations 7%
• Patient-centered Approach 7%
• Long-term Antibiotic Therapy 7%
• Methodologists 7%
• Content Expert 7%
• Guideline Panel 7%
• Multidisciplinary Panel 7%
• Oral Small Molecules 7%
• Refractory Pouchitis 7%
• Chronic Antibiotic Dependent Pouchitis 7%
• Small Molecule Drugs 7%
• Intolerant 7%

Medicine and Dentistry

• Pouchitis 100%
• Disease 100%
• Antibiotics 40%
• Immunosuppressive Treatment 20%
• Diseases 20%
• Ulcerative Colitis 13%
• Surgical Anastomosis 13%
• Antibiotic Therapy 13%
• Biological Product 6%
• Serositis 6%
• Inflammatory Bowel Disease 6%
• Proctocolectomy 6%
• Topical Corticosteroid 6%
• Methodologist 6%
• Patient with Ulcerative Colitis 6%
• Mesalazine 6%
• Probiotics 6%
• Oral 6%